BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jia Y, Zeng Z, Li Y, Li Z, Jin L, Zhang Z, Wang L, Wang FS. Impaired function of CD4+ T follicular helper (Tfh) cells associated with hepatocellular carcinoma progression. PLoS One. 2015;10:e0117458. [PMID: 25689070 DOI: 10.1371/journal.pone.0117458] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Guo Z, Liang H, Xu Y, Liu L, Ren X, Zhang S, Wei S, Xu P. The Role of Circulating T Follicular Helper Cells and Regulatory Cells in Non-Small Cell Lung Cancer Patients. Scand J Immunol 2017;86:107-12. [DOI: 10.1111/sji.12566] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
2 Wang Z, Rehman AU, Qin X, Zhu C, Wu S, Bukhari I. PI3K/AKT/mTOR Pathway-Associated Genes Reveal a Putative Prognostic Signature Correlated with Immune Infiltration in Hepatocellular Carcinoma. Disease Markers 2022;2022:1-18. [DOI: 10.1155/2022/7545666] [Reference Citation Analysis]
3 Wang B, Zhu J, Ma X, Qiu S, Pan B, Zhou J, Fan J, Yang X, Guo W. Tfr-Tfh index: A new predicator for recurrence of hepatocellular carcinoma patients with HBV infection after curative resection. Clin Chim Acta 2020;511:282-90. [PMID: 33080261 DOI: 10.1016/j.cca.2020.10.017] [Reference Citation Analysis]
4 Urbanowicz A, Zagożdżon R, Ciszek M. Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy. Arch Immunol Ther Exp (Warsz) 2019;67:79-88. [PMID: 30443787 DOI: 10.1007/s00005-018-0532-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
5 Ochando J, Braza MS. T follicular helper cells: a potential therapeutic target in follicular lymphoma. Oncotarget 2017;8:112116-31. [PMID: 29340116 DOI: 10.18632/oncotarget.22788] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
6 Cheng LS, Liu Y, Jiang W. Restoring homeostasis of CD4+ T cells in hepatitis-B-virus-related liver fibrosis. World J Gastroenterol 2015; 21(38): 10721-10731 [PMID: 26478664 DOI: 10.3748/wjg.v21.i38.10721] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
7 Xu F, Jin T, Zhu Y, Dai C. Immune checkpoint therapy in liver cancer. J Exp Clin Cancer Res. 2018;37:110. [PMID: 29843754 DOI: 10.1186/s13046-018-0777-4] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 18.0] [Reference Citation Analysis]
8 Lin X, Ye L, Wang X, Liao Z, Dong J, Yang Y, Zhang R, Li H, Li P, Ding L, Li T, Zhang W, Xu S, Han X, Xu H, Wang W, Gao H, Yu X, Liu L. Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21. Cancers (Basel) 2021;13:3678. [PMID: 34359579 DOI: 10.3390/cancers13153678] [Reference Citation Analysis]
9 Chen Y, Tian Z. HBV-Induced Immune Imbalance in the Development of HCC. Front Immunol 2019;10:2048. [PMID: 31507621 DOI: 10.3389/fimmu.2019.02048] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 12.0] [Reference Citation Analysis]
10 Qiu L, Yu Q, Zhou Y, Zheng S, Tao J, Jiang Q, Yuan G. Functionally impaired follicular helper T cells induce regulatory B cells and CD14+ human leukocyte antigen-DR- cell differentiation in non-small cell lung cancer. Cancer Sci 2018;109:3751-61. [PMID: 30325558 DOI: 10.1111/cas.13836] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
11 Guo Z, Chen Z, Xu Y, Zhang Y, Hu L, Yu F, Chai J, Liu L, Ren X. The Association of Circulating T Follicular Helper Cells and Regulatory Cells with Acute Myeloid Leukemia Patients. Acta Haematol 2020;143:19-25. [PMID: 31212277 DOI: 10.1159/000500588] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Hetta HF, Elkady A, Yahia R, Meshall AK, Saad MM, Mekky MA, Al-Kadmy IMS. T follicular helper and T follicular regulatory cells in colorectal cancer: A complex interplay. J Immunol Methods 2020;480:112753. [PMID: 32061875 DOI: 10.1016/j.jim.2020.112753] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Ly NTM, Ueda-Hayakawa I, Nguyen CTH, Okamoto H. Exploring the imbalance of circulating follicular helper CD4+ T cells in sarcoidosis patients. J Dermatol Sci 2020;97:216-24. [PMID: 32063460 DOI: 10.1016/j.jdermsci.2020.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Suk KT, Mederacke I, Gwak GY, Cho SW, Adeyemi A, Friedman R, Schwabe RF. Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis. Gut 2016;65:1721-32. [PMID: 27196571 DOI: 10.1136/gutjnl-2015-310212] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
15 Zhou Q, Zhang Q, Wang K, Huang T, Deng S, Wang Y, Cheng C. Anti-rheumatic Drug-induced Hepatitis B Virus Reactivation and Preventive Strategies for Hepatocellular Carcinoma. Pharmacol Res 2022;:106181. [PMID: 35301112 DOI: 10.1016/j.phrs.2022.106181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhang H, Yue R, Zhao P, Yu X, Li J, Ma G, Tang J, Zhang L, Feng L, Sun L, Song Z, Guo C, Wang N. Proinflammatory follicular helper T cells promote immunoglobulin G secretion, suppress regulatory B cell development, and correlate with worse clinical outcomes in gastric cancer. Tumour Biol 2017;39:1010428317705747. [PMID: 28631561 DOI: 10.1177/1010428317705747] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
17 Shi W, Dong L, Sun Q, Ding H, Meng J, Dai G. Follicular helper T cells promote the effector functions of CD8+ T cells via the provision of IL-21, which is downregulated due to PD-1/PD-L1-mediated suppression in colorectal cancer. Experimental Cell Research 2018;372:35-42. [DOI: 10.1016/j.yexcr.2018.09.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
18 Zhu Y, Li M, Bo C, Liu X, Zhang J, Li Z, Zhao F, Kong L, Yu J. Prognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinoma. Cancer Immunol Immunother 2017;66:343-54. [PMID: 27915370 DOI: 10.1007/s00262-016-1931-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
19 Wang Y, Wang L, Shi Y, Wang F, Yang H, Han S, Bai Y. Altered circulating T follicular helper cell subsets in patients with psoriasis vulgaris. Immunol Lett 2017;181:101-8. [PMID: 27662792 DOI: 10.1016/j.imlet.2016.09.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
20 Takagi K, Yagi T, Umeda Y, Shinoura S, Yoshida R, Nobuoka D, Kuise T, Araki H, Fujiwara T. Preoperative Controlling Nutritional Status (CONUT) Score for Assessment of Prognosis Following Hepatectomy for Hepatocellular Carcinoma. World J Surg 2017;41:2353-60. [DOI: 10.1007/s00268-017-3985-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 8.4] [Reference Citation Analysis]
21 Li M, Liang M, Lan T, Wu X, Xie W, Wang T, Chen Z, Shen S, Peng B. Four Immune-Related Long Non-coding RNAs for Prognosis Prediction in Patients With Hepatocellular Carcinoma. Front Mol Biosci 2020;7:566491. [PMID: 33364253 DOI: 10.3389/fmolb.2020.566491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
22 Zhao S, Xu W, Xie YX, Chen WW, Zhao M. CXCR5+ CD4+ T cell subsets and their relationship to immune dysfunction in chronic hepatitis B-associated liver cirrhosis. J Gastroenterol Hepatol 2020;35:689-95. [PMID: 31519041 DOI: 10.1111/jgh.14866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
23 Curran CS, Sharon E. PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma. Semin Oncol. 2017;44:428-432. [PMID: 29935904 DOI: 10.1053/j.seminoncol.2017.12.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
24 Meng T, Tong Z, Yang MY, Zhang Y, Liu Y, Wang ZZ, Zhu LX, Wu J. Immune implication of FAM83D gene in hepatocellular carcinoma. Bioengineered 2021;12:3578-92. [PMID: 34308751 DOI: 10.1080/21655979.2021.1950260] [Reference Citation Analysis]
25 Chulpanova DS, Kitaeva KV, Green AR, Rizvanov AA, Solovyeva VV. Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy. Front Cell Dev Biol 2020;8:402. [PMID: 32582698 DOI: 10.3389/fcell.2020.00402] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
26 Ye L, Li Y, Tang H, Liu W, Chen Y, Dai T, Liang R, Shi M, Yi S, Chen G, Yang Y. CD8+CXCR5+T cells infiltrating hepatocellular carcinomas are activated and predictive of a better prognosis. Aging (Albany NY) 2019;11:8879-91. [PMID: 31663864 DOI: 10.18632/aging.102308] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
27 Bruni D, Angell HK, Galon J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer 2020;20:662-80. [PMID: 32753728 DOI: 10.1038/s41568-020-0285-7] [Cited by in Crossref: 122] [Cited by in F6Publishing: 132] [Article Influence: 61.0] [Reference Citation Analysis]
28 Gao W, Zhou J, Ji B. Evidence of Interleukin 21 Reduction in Osteosarcoma Patients Due to PD-1/PD-L1-Mediated Suppression of Follicular Helper T Cell Functionality. DNA Cell Biol 2017;36:794-800. [PMID: 28650673 DOI: 10.1089/dna.2017.3669] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
29 Qian G, Wu M, Zhao Y, Li Q, Zhang M, Cai C, Tong D. Thyroid cancer metastasis is associated with an overabundance of defective follicular helper T cells. APMIS 2020;128:487-96. [PMID: 32562574 DOI: 10.1111/apm.13062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Sachdeva M, Chawla YK, Arora SK. Immunology of hepatocellular carcinoma. World J Hepatol 2015; 7(17): 2080-2090 [PMID: 26301050 DOI: 10.4254/wjh.v7.i17.2080] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 9.7] [Reference Citation Analysis]
31 Jia W, Zhang T, Yao Q, Li J, Nie Y, Lei X, Mao Z, Wang Y, Shi W, Song W. Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope. Front Immunol 2022;13:870458. [DOI: 10.3389/fimmu.2022.870458] [Reference Citation Analysis]
32 Dunn J, Rao S. Epigenetics and immunotherapy: The current state of play. Mol Immunol 2017;87:227-39. [PMID: 28511092 DOI: 10.1016/j.molimm.2017.04.012] [Cited by in Crossref: 113] [Cited by in F6Publishing: 105] [Article Influence: 22.6] [Reference Citation Analysis]
33 Huang M, Liu L, Zhu J, Jin T, Chen Y, Xu L, Cheng W, Ruan X, Su L, Meng J, Lu X, Yan F. Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Bladder Cancer. Front Cell Dev Biol 2021;9:723817. [PMID: 34532318 DOI: 10.3389/fcell.2021.723817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Vyas AK, Khosla R, Trehanpati N. In Response to 'The role of circulating T follicular helper cells and regulatory cells in non-small cell lung cancer patients'. Scand J Immunol 2017;86:248. [PMID: 28810080 DOI: 10.1111/sji.12584] [Reference Citation Analysis]
35 Bahria-Sediki IB, Yousfi N, Paul C, Chebil M, Cherif M, Zermani R, El Gaaied AB, Bettaieb A. Clinical significance of T-bet, GATA-3, and Bcl-6 transcription factor expression in bladder carcinoma. J Transl Med 2016;14:144. [PMID: 27237631 DOI: 10.1186/s12967-016-0891-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
36 Noël G, Fontsa ML, Garaud S, De Silva P, de Wind A, Van den Eynden GG, Salgado R, Boisson A, Locy H, Thomas N, Solinas C, Migliori E, Naveaux C, Duvillier H, Lucas S, Craciun L, Thielemans K, Larsimont D, Willard-Gallo K. Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity. J Clin Invest 2021;131:e139905. [PMID: 34411002 DOI: 10.1172/JCI139905] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Wang Y, Wang L, Yang H, Yuan W, Ren J, Bai Y. Activated Circulating T Follicular Helper Cells Are Associated with Disease Severity in Patients with Psoriasis. J Immunol Res 2016;2016:7346030. [PMID: 27774460 DOI: 10.1155/2016/7346030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
38 Ringelhan M, Pfister D, O'Connor T, Pikarsky E, Heikenwalder M. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19:222-232. [PMID: 29379119 DOI: 10.1038/s41590-018-0044-z] [Cited by in Crossref: 281] [Cited by in F6Publishing: 289] [Article Influence: 70.3] [Reference Citation Analysis]
39 Fathi F, Saidi RF, Banafshe HR, Arbabi M, Lotfinia M, Motedayyen H. Changes in immune profile affect disease progression in hepatocellular carcinoma. Int J Immunopathol Pharmacol 2022;36:3946320221078476. [PMID: 35226515 DOI: 10.1177/03946320221078476] [Reference Citation Analysis]
40 Poultsidi A, Dimopoulos Y, He TF, Chavakis T, Saloustros E, Lee PP, Petrovas C. Lymph Node Cellular Dynamics in Cancer and HIV: What Can We Learn for the Follicular CD4 (Tfh) Cells? Front Immunol 2018;9:2233. [PMID: 30319664 DOI: 10.3389/fimmu.2018.02233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
41 Stella L, Santopaolo F, Gasbarrini A, Pompili M, Ponziani FR. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment. World J Gastroenterol 2022; 28(21): 2251-2281 [DOI: 10.3748/wjg.v28.i21.2251] [Reference Citation Analysis]
42 Peeridogaheh H, Meshkat Z, Habibzadeh S, Arzanlou M, Shahi JM, Rostami S, Gerayli S, Teimourpour R. Current concepts on immunopathogenesis of hepatitis B virus infection. Virus Res. 2018;245:29-43. [PMID: 29273341 DOI: 10.1016/j.virusres.2017.12.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
43 Zaki MYW, Fathi AM, Samir S, Eldafashi N, William KY, Nazmy MH, Fathy M, Gill US, Shetty S. Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma. Cancers (Basel) 2022;14:1255. [PMID: 35267563 DOI: 10.3390/cancers14051255] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Ma QY, Huang DY, Zhang HJ, Chen J, Miller W, Chen XF. Function of follicular helper T cell is impaired and correlates with survival time in non-small cell lung cancer. Int Immunopharmacol 2016;41:1-7. [PMID: 27788370 DOI: 10.1016/j.intimp.2016.10.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
45 Duan Z, Gao J, Zhang L, Liang H, Huang X, Xu Q, Zhang Y, Shen T, Lu F. Phenotype and function of CXCR5+CD45RA-CD4+ T cells were altered in HBV-related hepatocellular carcinoma and elevated serum CXCL13 predicted better prognosis. Oncotarget 2015;6:44239-53. [PMID: 26517519 DOI: 10.18632/oncotarget.6235] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
46 Nedelkovska H, Rosenberg AF, Hilchey SP, Hyrien O, Burack WR, Quataert SA, Baker CM, Azadniv M, Welle SL, Ansell SM, Kim M, Bernstein SH. Follicular Lymphoma Tregs Have a Distinct Transcription Profile Impacting Their Migration and Retention in the Malignant Lymph Node. PLoS One 2016;11:e0155347. [PMID: 27228053 DOI: 10.1371/journal.pone.0155347] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
47 Hu B, Yang XB, Sang XT. Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients. Int Immunopharmacol 2021;90:107164. [PMID: 33172741 DOI: 10.1016/j.intimp.2020.107164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Pottier C, Wheatherspoon A, Roncarati P, Longuespée R, Herfs M, Duray A, Delvenne P, Quatresooz P. The importance of the tumor microenvironment in the therapeutic management of cancer. Expert Rev Anticancer Ther 2015;15:943-54. [PMID: 26098949 DOI: 10.1586/14737140.2015.1059279] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
49 Wang XQ, Ke X, Shen Y, Kang HY, Gu Z, Hu GH, Hong SL. Changes in circulating follicular helper T-cells in Chinese patients with allergic rhinitis. Acta Otolaryngol 2016;136:199-204. [PMID: 26472169 DOI: 10.3109/00016489.2015.1093169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]